Diagnosis and treatment of myocardial failure

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C435S091100, C435S091200, C536S023100, C536S024300

Reexamination Certificate

active

07049066

ABSTRACT:
The present invention provides methods of diagnosing myocardial failure in a human. The methods comprise obtaining a sample of myocardial tissue from a ventricle of the heart. In one embodiment, the expression of α-myosin heavy chain, β-myosin heavy chain, or both, are quantitated and their expression levels compared to that seen normal human ventricular myocardial tissues. In another embodiment, the expression of α1-thyroid hormone receptor, α2-thyroid hormone receptor, a α1-thyroid hormone receptor+β1-thyroid hormone receptor, or combinations thereof, are quantitated, and their expression levels compared to that seen normal human ventricular myocardial tissues. Therapeutic interventions based on altering the expression of the aforementioned genes also are provide.

REFERENCES:
patent: 5219727 (1993-06-01), Wang et al.
patent: 5476774 (1995-12-01), Wang et al.
patent: 5580722 (1996-12-01), Foulkes et al.
patent: WO 93/21339 (1993-10-01), None
Braunwald ed., 5d. Heart Disease , 1997 p. 406.
Mittman et al. J. Mol. Med.; 1998, vol. 76, pp. 133-140-abstract.
Levesque et al; BioTechniques, 1994, vol. 17, pp. 738-741.
Feldman et al. (Circulation, vol. 83, pp. 1866-1872, 1991.
Ahem, Holly; The Scientist, vol. 9, 1995, pp. 1-5.
Kurabayashi et al.; Japanese Circulation Journal, vol. 54 pp. 1192-1205; 1990.
Vrana et al;Molecular Brain Research, 1995, vol. 34, pp. 127-134.
Lowes et al (Assessment of gene expression in endomyocardial biopsy specimens from failing and nonfailing human hearts, J Clin. Investig. Med., Abstract, 316A, 1995.).
Bouvagnet et al (Basic Res. Cardiol. vol. 84, pp. 91-102, 1989).
Ladenson et al (PNAS, vol. 89, pp. 5251-5255, 1992).
Nadal-Grinard et al (J. Clin, Invest. vol. 84, pp. 1693-1700).
Kashani-Sabet et al. (Cancer Research, vol. 48, 5775-5778, 1988).
Arial et al.,Circulation Research,72:463-469, 1993.
Bouvagnet et al.,Basic Res. Cardiol.,84:91-102, 1989.
Bristow et al.,J. Clin. Invest.,92:2737-2745, 1993.
Calovini et al.,Journal Cell. Biochem.,59:69-78, 1995.
Chen et al.,Biochem. Biophys. Res. Communic.,188:547-553, 1992.
Colucci and Braunwald inHeart Disease: A textbook of cardiovascular medicine(Braunwald ed., 5thed., 1997), Chapter 13, p. 406.
Feldman et al.,Circulation,83:1866-1872, 1991.
Flink et al.,Febs Letters,94:125-130, 1978.
Flink et al.,Journal Biological Chem.,265:11233-11237, 1990.
Gustfson et al.,Proc. Natl. Acad. Sci. USA,84:3122-3126, 1987.
Hixson et al.,Mol. Cell. Cardiol.,21:1073-1086, 1989.
Izumo et al.,J. Clin. Invest.,79-970-977, 1987.
Kashani-Sabet et al.,Cancer Research,48:5775-5778, 1988.
Katz,New England Journal of Medicine,322:100-110, 1990.
Kurabayashi et al.,J. Clin. Invest.,82:524-531, 1988.
Kurabayashi et al.,Japanese Circulation Journal,54:1192-1205, 1990.
Ladenson et al.,Proc. Natl. Acad. Sci. USA,89:5251-5255, 1992.
Lowes et al., “Downregulation of α-and pregulation of β-Myosin Heavy Chain In Intact, Failing Human Ventricles,” Abstract,American College Cardiol.,46thAnnual Scientific Session, Feb. 1997.
Lowes et al., “Assessment of gene expression in endomyocardial biopsy specimens from failing and nonfailing human hearts,”J. Investigative Med.,Abstract, 316A, 1995.
Lowes et al.,J. Clin. Invest.,100:2315-2324, 1997.
Minobe et al.,JACC,277A, Feb. 1995.
Morkin et al.,Supplement III to Circulation Research,34 & 35: III-50-III-57, 1974.
Morkin et al.,Progress in Cardiovascular Disease,25:435-464, 1983.
Morkin et al.,Cellular and Molecular Mechanisms in Hypertension,pp. 143-147, 1991.
Morkin et al.,Circulation,87:1451-1460, 1993.
Nakao et al., “Alpha myosin heavy chain gene expression in non-failing and end-stage failing human left ventricles,” Abstract, Feb. 1997.
Nakao et al.,J. Clin. Invest.,100:2362-2370, 1997.
Pennock et al.,Journal of Pharmacology and Experimental Therapeutics,263:163-169, 1992.
Tsika et al.,Proc. Natl. Acad. Sci. USA,87:379-383, 1990.
Umeda et al.,Am J. Cardiol.,59:49A-55A, 1987.
Wang et al.,Proc. Natl. Acad. Sci. USA,86:9717-9721, 1989.
Vrana et al.,Molecular Brain Research,34:127-134, 1995.
Levesque et al.,Biotechniques,17:738-741, 1994.
Mittmann et al.,J. Mol. Med.(Berlin), 76:133-140, 1998.
Boluyt et al.,Circ. Res.,75:23-32, 1994.
Hanataini et al.,J. Cell. Cardiol.,27:1905-1914, 1995.
Nagai et al.,Circulation Research,60:692-699, 1987.
Umeda et al.,Circulation Suppl.,84:1408, Abstract 2378, 1996.
GenBank Accession No. D00943.
GenBank Accession No. X52889.
Khoury et al., “Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca2+-cycling proteins in the baboon,”Circulation Research,79(4):727-735, 1996.
Lompre et al., “Expression of the cardiac ventricular α- and β-myosin heavy chain genes is developmentally and hormonally regulated,”J. Biol. Chem.,259(10):6437-6446, 1984.
Moruzzi et al., “Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy,”Am. J. Med.,101:461-467, 1996.
Weiss and Leinwand, “The mammalian myosin heavy chain gene family,”Annu. Rev. Cell Dev. Biol.,12:417-439, 1996.
Clark et al., “Species correlations between cardiac isomyosins,”J Biol Chem,257:5449-5454, 1982.
Cummins & Lambert, “Myosin transitions in the bovine and human heart,”Circ. Res.,58:846-858, 1986.
Kitsis & Scheuer, “Functional significance of alterations in cardiac contractile protein isoforms,”Clin. Cardiol.,19:9-18, 1996.
Lompre et al, “Species- and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals,”Dev. Biol.,84:286-290, 1981.
Mercadier et al., “myosin isoenzymes in normal and hypertrophied human ventricular myocardium,”Circ. Res.,53:52-62. 1983.
Schier & Adelstein, “Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults and patients with hypertrophic cardiomyopathy,”J. Clin. Invest.,69:816:825, 1982.
Solaro, “Myosin and why hearts fail,”Circ.,85:1945-1947, 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnosis and treatment of myocardial failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis and treatment of myocardial failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of myocardial failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3541476

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.